SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-029014
Filing Date
2021-12-21
Accepted
2021-12-21 07:45:22
Documents
15
Period of Report
2021-12-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20211220_8k.htm   iXBRL 8-K 37885
2 EXHIBIT 99.1 ex_318361.htm EX-99.1 16888
7 a01.jpg GRAPHIC 4288
  Complete submission text file 0001437749-21-029014.txt   199566

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nby-20211217.xsd EX-101.SCH 3586
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20211217_def.xml EX-101.DEF 11422
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20211217_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20211217_pre.xml EX-101.PRE 11582
9 EXTRACTED XBRL INSTANCE DOCUMENT nby20211220_8k_htm.xml XML 2565
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 211506841
SIC: 2834 Pharmaceutical Preparations